Advertisement

Related Videos

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Peter Clark, MA, MD, FRCP: A Payer Perspective

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

David A. Hyman, MD, JD, on Inclusive Shared Savings

Advertisement

Advertisement




Jul
07
Today In Oncology
Preclinical Research Shows Interferon May Attenuate Neutrophil Response to Cancer Immunotherapy
AI-Powered Tumor Microenvironment Analysis May Predict Immunotherapy Response in Patients With Rare Cancers
Performance of Lung Cancer Risk Prediction Models Across Racial and Ethnic Groups in the United States
Study Uncovers How Obesity Influences Molecular Pathways in Breast Cancer Progression
Study Clarifies HPV-Related Cancer Risk in Immunosuppressed Populations
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo